Skip to main content

Lonza swings to pharma

Lonza has announced results for 2019, in which its growth was entirely driven by the Pharma Biotech & Nutrition division on which it will base its future.

Porton opens fermentation lab

Porton Pharma Solutions, a Chinese custom API services firm, has officially put into use its fermentation pilot laboratory at Chongqing, Sichuan province.

Advent buys ICE in Italy

Private equity investor Advent International has acquired Industria Chimica Emiliana (ICE) after 40 years of ownership by the Bortoli family, who developed the first laboratory bile acids.

Permira buys Cambrex

Cambrex has signed a definitive agreement to be acquired by an affiliate of private equity firm Permira, which has $48 billion of committed capital in its portfolio, covering healthcare among four other sectors.
Subscribe to Pharmaceuticals

 

 

AMRI web banner